Small Entity News Today

As of January 1, 2024, reporting requirements under the federal Corporate Transparency Act and related regulations (collectively, the "CTA") went into effect.

Consolidated Appropriations Act of 2023 contains Unleashing American Innovators Act of 2022, enacted December 29, 2022. Part of that law changed formula for calculating small and micro entity USPTO fee discounts. Small entities get 60% discount, micro entities get 80%.

If you get to page 1060 of the Consolidated Appropriations Act of 2023, you will see the Unleashing American Innovators Act of 2022, which was enacted on December 29, 2022.

If you get to page 1060 of the Consolidated Appropriations Act of 2023, you will see the Unleashing American Innovators Act of 2022, which was enacted on December 29, 2022. Part of that...

October marks the start of a new fiscal year for the USPTO. Last week the agency announced the extension of several pilot programs that will continue on into 2023 and beyond.

The Caner Immunotherapy Pilot Program/Patents 4 Patients program has been extend through January 31, the Fast-Track Appeals Pilot Program has been extended through July 2, 2024, and the After Final Consideration Pilot AFCP Program 2.0 has been extended to September 30, 2023

The US Patent & Trademark Office USPTO announced an extension of the modified COVID-19 Prioritized Examination Pilot Program. Compliant requests filed on or before March 31, 2022, will be accepted.

USPTO Changes Small Entity Rules To Promote CRADAs Tuesday, February 2, 2021 While I stand by my view that the doctrine of obviousness-type double patenting is one of the most complicated aspects of U.S. patent law, regulations governing the ability to claim “Small Entity” status and pay reduced USPTO fees come a close second. In a final rule effective January 20, 2021, the USPTO revised its Small Entity rules to remove disincentives of collaborating with the Federal government ...